VentriPoint Diagnostics logo

VPT - VentriPoint Diagnostics Share Price

C$0.085 0.0  0.0%

Last Trade - 5:23pm

Sector
Healthcare
Size
Micro Cap
Market Cap £4.13m
Enterprise Value £4.85m
Revenue £18.2k
Position in Universe 1907th / 2676
Bullish
Bearish
Unlock VPT Revenue
Momentum
Relative Strength (%)
1m -28.8%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -48.4%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
0.12 0.066 0.28 0.050 0.060 0.081 -7.9%
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the six months ended 30 June 2020, VentriPointDiagnostics Ltd. revenues decreased from C$50K to C$0K. Netloss applicable to common stockholders decreased 49% toC$1.1M. Revenues reflect a decrease in demand for theCompany's products and services due to unfavorable marketconditions. Lower net loss reflects General andadministrative decrease of 52% to C$478K (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

VPT Revenue Unlock VPT Revenue

Net Income

VPT Net Income Unlock VPT Revenue

Normalised EPS

VPT Normalised EPS Unlock VPT Revenue

PE Ratio Range

VPT PE Ratio Range Unlock VPT Revenue

Dividend Yield Range

VPT Dividend Yield Range Unlock VPT Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
VPT EPS Forecasts Unlock VPT Revenue
Profile Summary

Ventripoint Diagnostics Ltd., formerly Luca Capital Inc., is a medical device company. The Company is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. By using images produced from existing medical imaging systems, the Ventripoint Medical System (VMS) generates accurate heart volumetric measurements and a three-dimensional (3D) model in a rapid and inexpensive manner. The Company's solution produces critical heart information by processing standard information received from existing medical imaging equipment with its methods incorporating Knowledge Based Reconstruction (KBR) algorithms and cardiac databases (catalogues). Its technology platform is applicable to all heart diseases. The Company has developed prototype analytical software package to be used with 4D echocardiograms (VMS-4DE) and one to be used with magnetic resonance imaging (MRI) images (VMS-CMR). It also focuses on developing VMS-Plus and the VMS-Nano.

Directors
Last Annual December 31st, 2019
Last Interim June 30th, 2020
Incorporated September 18, 2007
Public Since November 9, 2005
No. of Shareholders: n/a
No. of Employees: n/a
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index
Exchange TSX Venture Exchange
Shares in Issue 89,094,351
Free Float (0.0%)
Eligible for
ISAs
SIPPs
VPT Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for VPT
Upcoming Events for VPT
Frequently Asked Questions for VentriPoint Diagnostics
What is the VentriPoint Diagnostics share price?

As of 5:23pm, shares in VentriPoint Diagnostics are trading at C$0.085, giving the company a market capitalisation of £4.13m. This share price information is delayed by 15 minutes.

How has the VentriPoint Diagnostics share price performed this year?

Shares in VentriPoint Diagnostics are currently trading at C$0.085 and the price has moved by 0% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the VentriPoint Diagnostics price has moved by -2.31% over the past year.

What are the analyst and broker recommendations for VentriPoint Diagnostics?

There are no analysts currently covering VentriPoint Diagnostics.

When will VentriPoint Diagnostics next release its financial results?

VentriPoint Diagnostics is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-06-30
What is the VentriPoint Diagnostics dividend yield?

VentriPoint Diagnostics does not currently pay a dividend.

Does VentriPoint Diagnostics pay a dividend?

VentriPoint Diagnostics does not currently pay a dividend.

When does VentriPoint Diagnostics next pay dividends?

VentriPoint Diagnostics does not currently pay a dividend.

How do I buy VentriPoint Diagnostics shares?

To buy shares in VentriPoint Diagnostics you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of VentriPoint Diagnostics?

Shares in VentriPoint Diagnostics are currently trading at C$0.085, giving the company a market capitalisation of £4.13m.

Where are VentriPoint Diagnostics shares listed? Where are VentriPoint Diagnostics shares listed?

Here are the trading details for VentriPoint Diagnostics:

Country of listing: Canada
Exchange: CVE
Ticker Symbol: VPT
What kind of share is VentriPoint Diagnostics?

Based on an overall assessment of its quality, value and momentum, VentriPoint Diagnostics is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a VentriPoint Diagnostics share price forecast 2020?

We were not able to load any forecast data for VentriPoint Diagnostics.

How can I tell whether the VentriPoint Diagnostics share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like VentriPoint Diagnostics. Over the past six months, the relative strength of its shares against the market has been 4.67%. At the current price of C$0.085, shares in VentriPoint Diagnostics are trading at -31.06% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the VentriPoint Diagnostics PE Ratio?

We were not able to find PE ratio data for VentriPoint Diagnostics.

Who are the key directors of VentriPoint Diagnostics?

VentriPoint Diagnostics's management team is headed by:

Danny Dalla-Longa - IND
George Adams - CEO
Ellen Briant - CFO
Alan Rabinowitz - DRC
David Willis - DRC
Donald Segal - DRC
Des Hirson - PRE
Alvira Macanovic - VOP
David McPhedran - DSL
Who are the major shareholders of VentriPoint Diagnostics?

Here are the top five shareholders of VentriPoint Diagnostics based on the size of their shareholding:

Dalla-Longa (Danny) Individual Investor
Percentage owned: 0.59% (524k shares)
Weichler (Peter) Individual Investor
Percentage owned: 0.21% (185k shares)
Adams (George) Individual Investor
Percentage owned: 0.07% (59.1k shares)
Similar to VPT
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.